15 High-Growth Companies with Big Revenue Targets for FY27 🚀

ELI5 / TLDR

The Q4 FY26 results season was actually good — revenue up 15%, profits up 23% across 3,500-odd companies — but the market is sulking because crude is near $100, foreigners dumped 2.2 lakh crore of Indian stocks, and the rupee is one of Asia’s worst performers. Shankar Nath ignores the price action and instead pulls out 15 companies where management has guided for big topline growth in FY27, ranging from a “modest” 25% to a doubling. It’s a watchlist, not a recommendation list — and the real value is less the 15 names than the checklist he hangs off each one: where is the growth coming from, is it sustainable, and what does it do to margins.

The Full Story

The setup: good results, bad mood

Nath opens with the disconnect everyone in Indian markets is living through. The numbers are fine — Q4 FY26 was the strongest quarter in three years. The mood is not.

“It won’t be wrong to say that some sort of sentimental fatigue has set in which normally happens when the market isn’t going anywhere wherein investors are now far more sensitive to bad news than the good news.”

His move is to look past the screen price and at the business. Stock price is a bet on the future; revenue guidance is management telling you what they think that future looks like. So the whole video is built around one question repeated 15 times: a company says it’ll grow X% next year — should you believe it, and what should you check?

The recurring checklist

The names matter less than the muscle he’s trying to build. For nearly every company he asks the same things: don’t look at revenue growth in isolation, look at where it comes from (a specific contract, a new product line, an order book), whether it’s sustainable, and what it does to the operating margin. He keeps flagging that these stocks carry high price-to-earnings multiples — and that the “E” in that ratio is the trailing twelve months, not the future. A company growing 40% can look expensive today and cheap in hindsight. His example: Dixon Technologies, which used to trade at 150-200x earnings and has since “normalized” to under 50x as profits caught up.

The 15 names, by theme

A few clusters emerge.

Chemicals and pharma contract manufacturing. Aequitas Chemicals (the old Ami Organics) guides 25%, driven by a contract-manufacturing (CDMO) deal with Fermion to supply the active ingredient for a prostate cancer drug. Nath spends real time here on the risk of this model — using BlueJet Healthcare as a cautionary tale, where one client (Esperion) abruptly de-stocked and moved manufacturing elsewhere, gutting BlueJet’s orders for several quarters. CDMO revenue is lumpy; one client can swing it. Quality Pharma is a steadier B2B medicine-maker targeting 650 crore (29% growth) heading toward 1,000 crore by FY29.

Electrification — the fattest cluster. Atlanta Electricals (power transformers, ~2,500 crore order book, 40% target). Genus Power (smart meters, a 25,000 crore order book but margins slipping to 17.4% because it signs fixed-price contracts with no way to pass on raw-material inflation). Transformers & Rectifiers India (TARIL) — the cautionary one: missed its order-book target, margins compressed, and its CEO resigned within six months. When asked for an FY27 number the MD first said one thing, then a different thing.

“When this question was again posed to him his answer was slightly different … Not a very comforting sign had I been the shareholder or a prospective investor.”

Yash High Voltage makes the bushings that let electricity in and out of transformers — so its demand rides on everyone else’s transformer growth — targeting 50-70%.

Recycling / metals. Gravita India (lead recycler pivoting hard into copper; the pitch is that copper throws off 60-65,000 rupees of operating profit per tonne versus 20,000 for lead). Namo eWaste — an electronics recycler targeting a 110% doubling, but with a flag: it’s listed on the SME exchange, not the main board, so oversight is thinner. Treat with care.

The interesting oddballs. Cupid Ltd, a condom and sexual-wellness maker, posted 100%+ growth for three straight quarters and targets 600 crore (68% growth) — though Nath flatly calls it “very expensive,” noting the promoter has been buying shares. Solar Industries (nothing to do with solar — industrial explosives and defence munitions) targets 14,000 crore (42%), riding a defence order book of 18,000 crore. Rosel Texas/Rossell Techsys (aerospace wiring) targets ~80-90% growth and “has almost always been available at a P/E of 100 and beyond.” Sky Gold (B2B jewellery) projects a “merely” 28.6% — slow for a company used to 50%+. Deep Industries (oilfield services) stands out for guiding 25-30% while trading at a P/E of just 8. Aeroflex Industries makes flexible steel hoses and has lucked into the AI boom via liquid-cooling “skid assemblies” for data centres. Krishana Phoschem (fertilisers) targets 35-40%, in a sector Nath openly dislikes for its raw-material and monsoon exposure.

The honest closing

Nath is upfront that this is one of three ways to play high-growth names: ride the wave now and accept paying up, wait for “something to go horribly wrong” and buy the dip, or pick them young before the breakout. He also admits the gaps — there are “100 plus companies not included here” — and that he’s a shareholder in at least Sky Gold, where he thinks the far-out FY30 target is “a bit challenging.”

Key Takeaways

Market context: Q4 FY26 was the best quarter in 3 years (revenue +15%, operating profit +20%, net profit +23%), yet sentiment is poor due to ~$100 crude, FII selling of 2.2 lakh crore in FY26, a rupee near 96/USD, and six straight months of rising inflation.
Aequitas Chemicals (ex-Ami Organics): 25% guidance, CDMO-led, anchored by a multi-year Fermion contract for a prostate cancer drug ingredient. Operating margin jumped from ~17-20% to over 35%. CDMO risk illustrated via BlueJet Healthcare’s client-concentration blowup.
Aeroflex Industries: 35% guidance; flexible steel flow products, ~70% exports; new angle is liquid-cooling skid assemblies for AI data centres (sold ~600 units, targeting 15,000/month).
Atlanta Electricals: ~40% revenue CAGR target through FY28; ~2,500 crore order book in power transformers, shifting toward higher-margin 400kV/765kV units.
Cupid Ltd: sexual-wellness products; 100%+ growth in three straight quarters; FY27 target 600 crore (68% growth) at 30%+ margins. Nath: “very expensive.” Promoter accumulating shares.
Deep Industries: oilfield services; 25-30% guidance for FY27-28, notably cheap at P/E ~8.
Genus Power: smart meters; revenue nearly doubled to ~4,700 crore in FY26; FY27 target 6,000-6,500 crore (26-37%); order book over 25,000 crore but margins squeezed to 17.4% by fixed-price contracts with no raw-material pass-through.
Gravita India: 20-25% volume growth; pivoting from lead to copper recycling (copper EBITDA ~60-65k/tonne vs ~20k for lead); targeting 100,000+ tonnes copper capacity by FY29.
Krishana Phoschem: fertilisers (SSP/DAP/NPK); 35-40% target; FY26 revenue +78%, PAT +107%, but margins may soften.
Quality Pharma: B2B medicines across 70+ countries; 650 crore FY27 target (29%), 1,000 crore by FY29; expanding into regulated markets (Europe).
Namo eWaste: e-waste recycler targeting 400 crore (110% growth); SME-listed, so weaker oversight — Nath flags higher risk.
Rosel Texas (Rossell Techsys): aerospace/defence wiring; ~80-90% target; 715 crore confirmed order book plus 3,000 crore strategic agreements; P/E routinely 100+.
Sky Gold: B2B 22k gold jewellery; FY26 revenue ~6,000 crore (+77%); FY27 target 8,100 crore (“only” 28.6%); margins thin at 7-7.5%. Nath is a shareholder.
Solar Industries: industrial explosives + defence; FY27 target 14,000 crore (42%); 21,000 crore order book (18,000 crore defence, biggest order “Pinaka”); expanding across Africa, Turkey, SE Asia.
TARIL (Transformers & Rectifiers India): the red-flag name — missed FY26 order-book target, margin compression (19.4%→15.1%), project delays, CEO resigned within 6 months; management gave inconsistent FY27 numbers (29.5% vs 35-40%).
Yash High Voltage: transformer bushings; FY27 target 360-400 crore (50-70%); capacity expanding 10,000→16,000 bushings; market cap under 2,000 crore.

Claude’s Take

This is a competent, honest screening video — and worth being clear-eyed about what it is. Every single number here is management guidance, not Nath’s analysis. “High-growth companies with big targets” is a list of promises companies made about themselves on earnings calls. Managements are structurally optimistic; guidance is marketing with a spreadsheet attached. The TARIL section is the tell — Nath catches the MD changing his FY27 number mid-conversation, which is exactly the kind of thing that should make you discount the cheerful numbers from the other fourteen.

What raises this above the usual “multibagger stocks” clickbait is that Nath knows this and keeps undercutting his own list. He repeatedly tells you to check where the growth comes from, what it does to margins, and that the trailing P/E makes everything look scarier than it is. He calls Cupid “very expensive,” flags Namo’s SME listing, dislikes the fertiliser sector out loud, and admits his own Sky Gold target looks stretched. That’s a content creator behaving more like an analyst than a hype man. The BlueJet digression — using one company’s client-concentration disaster to teach the CDMO risk — is genuinely the best two minutes of the video.

The weakness is unavoidable: 15 companies in 30 minutes is ~2 minutes each, which is enough to put a name on your radar and not remotely enough to underwrite buying anything. There’s no valuation work, no balance-sheet check, no competitive analysis. Treat it as a sourcing tool — a list of leads to run through a real process — not as conclusions. Score 6: above-average for the genre because of the repeated “here’s what to actually check” scaffolding and the willingness to flag warts, but capped because the core deliverable is recycled management guidance.